Drug price slash unlikely to bring insurance fund saving effects

Published: 2000-12-07 17:45:00

Updated: 2000-12-07 17:45:00

Managing director Shin Suk-woo of the KPMA reported a study paper titled "the pharmaceutical industry development in the 21st century" in the seminar held at Moonmak, Kangwon province on Dec. 1. He suggested in the meeting that the overall drug price reduction having slashed by the government sin...

Fees

- Email service daily and homepage access.

$300 per month. ($3,240 per year)
5 Email holders per each company.
Anual contract base.

Latest News

Which are outstanding tetravalent vaccines even for the young?

Disease treated the most with clinical trial drugs is respiratory disorder like lung cancer

Who will be the next Pharmaceutical Safety Bureau Director?

Celltrion completes clinical trials for Remsima SC for European approval

Sales listed pharmas made in the first half of the year

TOP

BACK